Abstract

In this study, a mechanism in which low-dose hyper-radiosensitivity (HRS) is permanently removed, induced by low-dose-rate (LDR) (0.2–0.3 Gy/h for 1 h) but not by high-dose-rate priming (0.3 Gy at 40 Gy/h) was investigated. One HRS-negative cell line (NHIK 3025) and two HRS-positive cell lines (T-47D, T98G) were used. The effects of different pretreatments on HRS were investigated using the colony assay. Cell-based ELISA was used to measure nitric oxide synthase (NOS) levels, and microarray analysis to compare gene expression in primed and unprimed cells. The data show how permanent removal of HRS, previously found to be induced by LDR priming irradiation, can also be induced by addition of nitric oxide (NO)-donor DEANO combined with either high-dose-rate priming or exposure to prolonged cycling hypoxia followed by reoxygenation, a treatment not involving radiation. The removal of HRS appears not to involve DNA damage induced during priming irradiation as it was also induced by LDR irradiation of cell-conditioned medium without cells present. The permanent removal of HRS in LDR-primed cells was reversed by treatment with inducible nitric oxide synthase (iNOS) inhibitor 1400W. Furthermore, 1400W could also induce HRS in an HRS-negative cell line. The data suggest that LDR irradiation for 1 h, but not 15 min, activates iNOS, and also that sustained iNOS activation is necessary for the permanent removal of HRS by LDR priming. The data indicate that nitric oxide production is involved in the regulatory processes determining cellular responses to low-dose-rate irradiation.

Details

Title
The role of nitric oxide radicals in removal of hyper-radiosensitivity by priming irradiation
Author
Nina Jeppesen Edin 1 ; Sandvik, Joe Alexander 2 ; Vollan, Hilde Synnøve 3 ; Reger, Katharina 4 ; Görlach, Agnes 4 ; Pettersen, Erik Olai 2 

 Department of Physics, University of Oslo, 0316 Oslo, Norway; Department of Radiation Biology, Institute for Cancer Research, University Hospital, University of Oslo, 0310 Oslo, Norway 
 Department of Physics, University of Oslo, 0316 Oslo, Norway 
 Department of Clinical Molecular Biology (EpiGen), Institute of Clinical Medicine, Akershus University Hospital, University of Oslo, 1478 Lørenskog, Norway 
 Experimental and Molecular Pediatric Cardiology, Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Lazarettstr. 36, 80636 Munich, Germany 
Pages
1015-1028
Publication year
2013
Publication date
Nov 2013
Publisher
Oxford University Press
ISSN
04493060
e-ISSN
13499157
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170877743
Copyright
© The Author 2013. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.